QMS Medical reports FY26 revenue of INR172.9 crores

1 min read     Updated on 11 Jun 2026, 07:58 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

QMS Medical Allied Services released the transcript for its FY26 earnings call, reporting an 11% rise in revenue to INR172.9 crores. EBITDA stood at INR25.9 crores with a PAT of INR11.9 crores. The product segment contributed 69% of revenue, while services contributed 31%, supported by 32,380 healthcare camps.

powered bylight_fuzz_icon
41879807

*this image is generated using AI for illustrative purposes only.

QMS Medical Allied Services Limited has released the transcript of its earnings call for the half year and year ended March 31, 2026. The company reported an 11% year-on-year growth in revenue from operations, which reached INR172.9 crores for FY26. EBITDA stood at INR25.9 crores, while profit after tax was INR11.9 crores. The financial results were approved by the Board on May 30, 2026, and the disclosure was submitted to the National Stock Exchange of India Ltd.

Financial Performance

The company delivered steady growth despite a challenging environment, driven by its two complementary business pillars: products and services. Over the last three years, QMS Medical has achieved an 18% revenue CAGR, a 32% EBITDA CAGR, and a 23% PAT CAGR.

Metric FY26 Value
Revenue from Operations INR172.9 crores
EBITDA INR25.9 crores
Profit After Tax INR11.9 crores

Business Segments

The product segment contributed approximately 69% of the total revenue, supported by a portfolio of over 900 SKUs. The services segment, which includes healthcare screening camps and patient engagement programs, contributed 31% of the revenue. During FY26, the company successfully conducted 32,380 healthcare camps across India. To strengthen its position in patient support programs, QMS Medical increased its stake in Saarathi Healthcare to 76%.

Future Outlook

Management remains optimistic about future opportunities, citing the shift towards patient-focused engagement in the healthcare sector. The company has invested in people, technology, and infrastructure to support long-term growth, particularly in patient service programs. These investments are expected to drive scalability and improve healthcare outcomes.

Historical Stock Returns for QMS Medical Allied Services

1 Day5 Days1 Month6 Months1 Year5 Years
+1.65%+1.49%+16.59%+13.22%+23.22%-20.64%

How will the increased stake in Saarathi Healthcare contribute to revenue growth in the next fiscal year?

What are the expected financial impacts of the recent investments in technology and infrastructure?

How does QMS Medical plan to expand its product portfolio beyond the current 900 SKUs?

QMS Medical Allied Services
View Company Insights
View All News
like17
dislike

QMS Medical promoters disclose shareholding under SEBI regulations

1 min read     Updated on 06 Jun 2026, 05:20 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

QMS Medical Allied Services disclosed shareholding details for its promoters and promoter group members as of March 31, 2026, in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Promoter Mahesh Paharaj Makhija holds 1,28,48,840 equity shares, while promoter group members Guddi Mahesh Makhija and Diti Mahesh Makhija hold 1,59,630 and 1,63,116 equity shares, respectively. All disclosed shares are not encumbered either directly or indirectly.

powered bylight_fuzz_icon
42292215

*this image is generated using AI for illustrative purposes only.

qms medical allied services disclosed the shareholding details of its promoters and promoter group members for the period ending March 31, 2026. The disclosure was submitted to the National Stock Exchange of India Ltd. in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that the shares held by these individuals are not encumbered either directly or indirectly.

Promoter Holdings

Mahesh Paharaj Makhija, a promoter of the company, declared a holding of 1,28,48,840 equity shares. This constitutes the largest individual holding among the disclosures provided to the exchange.

Promoter Group Holdings

Members of the promoter group also submitted their annual disclosures. Guddi Mahesh Makhija reported holding 1,59,630 equity shares, while Diti Mahesh Makhija disclosed a holding of 1,63,116 equity shares. Both individuals confirmed that their respective shareholdings are free from any encumbrance.

The following table summarizes the disclosed shareholding details as of March 31, 2026:

Shareholder Category Equity Shares Held
Mahesh Paharaj Makhija Promoter 1,28,48,840
Guddi Mahesh Makhija Promoter Group 1,59,630
Diti Mahesh Makhija Promoter Group 1,63,116

The disclosures were signed and submitted by the respective shareholders on April 6, 2026. The company, through its Company Secretary and Compliance Officer Toral Jailesh Bhadra, forwarded these details to the stock exchange on April 7, 2026.

Historical Stock Returns for QMS Medical Allied Services

1 Day5 Days1 Month6 Months1 Year5 Years
+1.65%+1.49%+16.59%+13.22%+23.22%-20.64%

How might the unencumbered status of promoter shares influence potential acquisition or takeover strategies?

Could this disclosure signal upcoming changes in the company's capital structure or dividend policy?

What impact might these holdings have on shareholder voting power and corporate governance decisions?

QMS Medical Allied Services
View Company Insights
View All News
like20
dislike

More News on QMS Medical Allied Services

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+23.22%